Enveric Biosciences, Inc.

Enveric Biosciences, Inc., a biotechnology company, engages in developing various cannabinoid medicines to enhance quality of life for cancer patients. It has a pipeline of development programs for radiodermatitis, glioblastoma, and chemotherapy-induced neuropathy. Show More...

  • Website http://www.enveric.com
  • Sector Healthcare
  • Industry Biotechnology
  • Last Quote 1.18 USD
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share USD -17.61 -6.95 -3.57 -0.02 -3.89 -7.0 -21.0 -75.0 -81.88 -11.32 -8.96
    Dividends USD
    Payout Ratio % *
    Shares Mil 1.0 1.0
    Book Value Per Share * USD 2.42 -2.91 -4.82 0.78 8.07 34.23 67.16 71.08 21.0 0.72
    Free Cash Flow Per Share * USD -7.2 -3.6 -3.62 -4.81 -1.9 -31.49 -36.31 -12.82 -6.48
    Return on Assets % -283.17 -175.55 -3.2 -704.37 -27.32 -10.43 -24.35 -47.61 -22.07 -26.64
    Financial Leverage (Average) 4.93 53.51 3.39 2.68 2.76 2.36 2.13
    Return on Equity % -46.67 -71.79 -129.02 -56.43 -55.12
    Return on Invested Capital % -27.53 -20.1 -49.45 -94.25 -35.13 -37.0
    Interest Coverage -7.47 -7.69 -18.94 -13.45 -6.55
    Current Ratio 0.02 1.25 0.22 0.18 0.57 0.84 0.79 0.48 0.69 0.53 0.81
    Quick Ratio 0.02 1.02 0.05 0.010 0.57 0.8 0.75 0.45 0.63 0.47 0.74
    Debt/Equity 19.34 0.13 0.12 0.06